Infant Formula Manufacturing in European Union 2026: Industry Statistics & Trends

The infant formula manufacturing industry in the European Union involves the highly controlled production of specialized dairy and plant-based nutritional formulations designed for infants under 12 months. Represented regionally by Specialised Nutrition Europe (SNE), the sector's output forms a vital component of the EU agrifood economy, with the broader specialized nutrition sector achieving an annual turnover of approximately €24 billion as of 2024 (Specialised Nutrition Europe). Operating within a challenging demographic environment of declining birth rates, the industry is increasingly shifting toward premium, organic, and functionally enhanced formulations. The market's direction is hea

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Infant Formula Manufacturing in European Union industry cover?

This industry comprises establishments primarily engaged in the processing, blending, and packaging of infant formulas, follow-on formulas, and special medical nutrition preparations for infants. The scope of production spans cow's milk, goat's milk, and plant-based bases (such as soy or rice) transformed into powdered, concentrated, or liquid ready-to-feed formats. These products are formulated to act as the sole source of nutrition for infants or as the principal liquid element in a progressively diversified diet.

• •Covers infant formula (0-6 months) and follow-on formula (6-12 months) as harmonized under EU regulations.
• •Includes specialized infant formulas for special medical purposes (iFSMPs) to address conditions like severe allergies or prematurity.
• •Excludes unregulated toddler or 'growing-up' milks (1-3 years), which trade groups are actively lobbying to bring under standard EU frameworks.

Who operates in the industry and how is it structured?

The European manufacturing landscape is highly concentrated and characterized by a small number of sophisticated processing facilities that supply both the domestic EU Single Market and global export destinations. Production is anchored by massive dairy processing infrastructures, particularly in member states with high raw milk yields such as Germany, France, and the Netherlands. Operators leverage advanced industrial drying, blending, and aseptic packaging technologies to meet stringent chemical and biological safety standards.

• •Specialised Nutrition Europe represents national associations across 19 European countries, encompassing approximately 104 specialized production plants.
• •The sector employs an estimated 13,800 people directly across its European manufacturing operations.
• •The EU dairy sector produced 2.7 million tonnes of dairy powder products in 2024, providing the core raw material (skimmed milk, whole milk, and whey) utilized in formula blending.

What drives demand in the industry?

Demand is driven by parental preferences for high-quality, safe, and convenient nutrition, coupled with rising female labor force participation rates across Europe. Because volume growth is constrained by long-term demographic declines in European birth rates, manufacturers focus on value-driven growth through premiumization. This includes rising consumer demand for organic certifications, clean-label ingredients, and specialized formulations that support cognitive and immunological development.

• •Organic baby food formulations represent a major growth focus, supported by the EU's Farm to Fork target to achieve 25% organic farmland by 2030.
• •Demand is rising for alternative bases, with goat's milk formulations increasing to capture approximately 10% of new product launches in the European market.
• •Ingredient innovation is heavily driven by mandated and recommended additives, such as docosahexaenoic acid (DHA) and arachidonic acid (ARA).

Who are the notable companies in the industry?

The European competitive landscape is dominated by a select group of multinational food and life science conglomerates alongside specialized regional dairy cooperatives. These entities possess the capital necessary to maintain compliant, high-tech manufacturing facilities and fund extensive clinical research. Market players compete fiercely on the basis of brand trust, scientific formulation, and distribution reach across pharmacies, supermarkets, and online retail channels.

• •Danone SA is a leading European market participant, recording €9.3 billion in global specialized nutrition sales in 2025.
• •Nestlé SA is the world's largest infant formula producer, operating key European manufacturing sites such as its facility in Boué, France.
• •Royal FrieslandCampina N.V. is a major Dutch dairy cooperative operating a highly integrated supply chain from dairy farming to specialized infant nutrition ingredients.
• •Other prominent entities actively manufacturing or distributing infant formula in Europe include Switzerland-based Hero Group and the Irish nutrition group Glanbia plc.

What are the recent trends and outlook?

The industry is adapting to significant supply chain and regulatory pressures, highlighted by a major multi-country recall of infant formula in late 2025 and early 2026 due to cereulide toxin contamination. This event has intensified scrutiny on the global sourcing of specialty ingredients, such as ARA oils, and accelerated efforts to define stricter safety thresholds. Looking forward, manufacturers are focusing on sustainable packaging innovations and the integration of Human Milk Oligosaccharides (HMOs) produced via precision fermentation.

• •A major product safety investigation was initiated in early 2026 following contaminated formula recalls across more than 60 countries, tracing back to an ingredient supplier.
• •The European Food Safety Authority (EFSA) is establishing an official 'acute reference dose' for cereulide in infant formula to standardize future recall triggers.
• •Packaging formats are steadily shifting from traditional tin cans to lightweight pouches to reduce manufacturer shipping costs and carbon footprints.

How is the industry regulated?

Infant formula is one of the most strictly regulated food categories in the European Union, subject to rigorous standards governing composition, labeling, and marketing. Regulations dictate precise minimum and maximum levels for macro- and micronutrients, while strictly limiting pesticide residues and chemical contaminants. Additionally, the EU enforces tight restrictions on the advertising and promotion of infant formulas to protect and promote breastfeeding.

• •Governed by Regulation (EU) No 609/2013 (Food for Specific Groups) and supplemented by Commission Delegated Regulation (EU) 2016/127.
• •The EU legally mandates the addition of docosahexaenoic acid (DHA) to all infant and follow-on formulas to support brain development.
• •EU law prohibits the use of 'silent recalls,' requiring immediate public notification the moment a potentially unsafe product is suspected to have reached consumers.

Government, statistical and trade sources used for this Claight analysis.

• Eurostat Milk and Milk Product Statistics 2024 ·
• Specialised Nutrition Europe (SNE) Industry Figures 2024 ·
• European Commission Report on Food for Specific Groups (FSG) 2016 ·
• European Food Safety Authority (EFSA) Scientific Opinions 2026